NEW YORK – Abbott announced Tuesday the US Food and Drug Administration granted Emergency Use Authorization to the company's RealTime SARS-CoV-2 test for use with the Alinity m platform.
The PCR-based test was previously authorized in March for use with the firm's m2000 RealTime system.